Ceramide is a promising new clinical diagnostic test for the identification of patients at risk of heart problems. ED often predates heart attacks by 3-5 years. Heart disease remains the No. 1 cause of death both within the U.S. and globally. Consequently, there is an ongoing search for risk factors to help identify and treat patients prior to the development of symptomatic heart disease.
Multiple published studies have repeatedly confirmed the strong predictive value of ceramides. Risk conferred by plasma ceramides is independent of traditional risk factors including age, sex, body-mass index, smoking status and blood cholesterol.